NanoLogix Inc. to Exhibit at The American Society for Microbiology (ASM) General Meeting in Philadelphia; Announces Two New Patents
NanoLogix had recently received two patents. U S 7,524,623 is for a "Method and device for rapid detection of microorganisms by changing the shape of micro-colonies" which is for BNC(TM) rapid-detection technology is the first US patent granted. Christopher Novak, NanoLogix Director of Intellectual Property has told that the issuance of the first US patent for the BioNanoChannel(TM) (BNC) this past week is a very significant development for NanoLogix as thist provides NanoLogix with not only substantial intellectual property protection for their revolutionary rapid-detection technology but also strengthens NanoLogix's patent portfolio with additional patents anticipated in the family of patent applications on file for this technology.
BNP(TM) and BNC(TM) are two distinct micro-biological rapid-detection technologies developed by NanoLogix. The BNP is a sandwiched-membrane, Petri-based system, that provides users with the ability to view microorganism cultures up to four times faster than possible with traditional Petri techniques. The BNC is also a unique development in rapid detection which utilizes disks of quarter size, each containing over two-million channels, to trap microorganisms for identification and culturing. Both BNP and BNC technologies offer the potential for reducing time-to-detection by significant amounts when contrasted with current methods in widespread use.
Another patent US 7,473,552 for the "Production of hydrogen gas and isolation of hydrogen producing microorganisms using replenishing coated substrates" was also recently received. The company has added this patent to their existing archived hydrogen-related research portfolio
With these patents in hand, NanoLogix, Inc. personnel will display the company's BNP(TM) rapid-detection technology at booth 749 during the 109th Annual ASM Meeting to be held at the Pennsylvania Convention Center in Philadelphia May 17th - 21st. The ASM meeting is the world's premier event for microbiology development. Representing NanoLogix will be Dr. Sergey Gazenko and CEO Bret Barnhizer. Exhibition information can be found at http://gm.asm.org/
This site is best viewed with Internet Explorer 6.0 or higher, Firefox 2.0 or higher at a minimum screen resolution of 1024x768.
Copyright PatIntNews.Com 2007. All Right Reserved